GB1502873A - Pharmaceutical compositions with ulcer healing activity - Google Patents

Pharmaceutical compositions with ulcer healing activity

Info

Publication number
GB1502873A
GB1502873A GB14091/75A GB1409175A GB1502873A GB 1502873 A GB1502873 A GB 1502873A GB 14091/75 A GB14091/75 A GB 14091/75A GB 1409175 A GB1409175 A GB 1409175A GB 1502873 A GB1502873 A GB 1502873A
Authority
GB
United Kingdom
Prior art keywords
compositions
ulcer healing
pharmaceutical compositions
april
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14091/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Publication of GB1502873A publication Critical patent/GB1502873A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/915Aspergillus flavus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/916Aspergillus fumigatus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/917Aspergillus niger
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/918Aspergillus oryzae

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB14091/75A 1974-04-08 1975-04-07 Pharmaceutical compositions with ulcer healing activity Expired GB1502873A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2416978A DE2416978A1 (de) 1974-04-08 1974-04-08 Arzneimittel mit dem hauptsapogenin der helleborus-arten als wirkstoff

Publications (1)

Publication Number Publication Date
GB1502873A true GB1502873A (en) 1978-03-08

Family

ID=5912425

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14091/75A Expired GB1502873A (en) 1974-04-08 1975-04-07 Pharmaceutical compositions with ulcer healing activity

Country Status (7)

Country Link
US (1) US3956491A (enExample)
AT (1) AT338968B (enExample)
BE (1) BE827659A (enExample)
DE (1) DE2416978A1 (enExample)
FR (1) FR2266509B1 (enExample)
GB (1) GB1502873A (enExample)
NL (1) NL7504106A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302611A (en) * 1980-10-07 1994-04-12 Klaus Keplinger Oxindole alkaloids having properties stimulating the immunologic system & preparation containing the same
MX164619B (es) * 1988-03-02 1992-09-09 Vicente Parrilla Cerrillo Composicion para el tratamiento de lesiones cutaneas
US5290557A (en) * 1992-07-16 1994-03-01 W. Neudorff Gmbh Kg Saponin containing anti-feedant and molluscicide for terrestrial mollusc control
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
TR200002773T2 (tr) * 1998-03-26 2001-11-21 Phytopharm Plc Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
RU2207141C2 (ru) * 2001-08-10 2003-06-27 Паршичев Герман Владимирович Биологически активный препарат - масло морозника
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366M (fr) * 1962-10-17 1964-03-02 Jouveinal Lab Médicament antiphlogistique a base de ruscogénine.

Also Published As

Publication number Publication date
BE827659A (fr) 1975-10-07
AT338968B (de) 1977-09-26
FR2266509B1 (enExample) 1980-01-04
US3956491A (en) 1976-05-11
ATA266775A (de) 1977-01-15
NL7504106A (nl) 1975-10-10
FR2266509A1 (enExample) 1975-10-31
DE2416978A1 (de) 1975-10-09

Similar Documents

Publication Publication Date Title
MY101784A (en) Novel pharmacological compounds
GB1502873A (en) Pharmaceutical compositions with ulcer healing activity
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
ATE171066T1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
GB1418208A (en) Pharmaceutical compositions
GB1334327A (en) Compositions for and method of combating virus infections
GB1170132A (en) Esters of d-Pantothenol
GB1291559A (en) N-(4-chlorocinnamoyl)-4-hydroxypiperidine
GB1508338A (en) Pharmaceutical compositions
GB1429977A (en) Diuretic composition
GB1352392A (en) Phenylisopropylamine derivatives
GB1359044A (en) Quinoline derivatives
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
GB1197389A (en) Heterocyclic Dithiocarboxylic Acids
IE39587L (en) Antibacterial composition
GB1353834A (en) Benzenesulphonamides
GB1176049A (en) N-Substituted Noratropinium Salts
GB1296911A (enExample)
IE34313B1 (en) 2-hydroxy-5-amino-benzamide derivatives
GB1463260A (en) Pharmacologically active acetic acid derivative
GB1454390A (en) Nasal decongestants
SE329398B (enExample)
GB1304697A (enExample)
GB1279185A (en) Improvements in or relating to pharmaceutical compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee